Noninferiority trials comparing new treatment with an active standard control are becoming increasingly common. This article discusses relevant issues regarding their need, design, analysis and interpretation: the appropriate choice of control group, types of noninferiority trial, ethical considerations, sample size determination and potential pitfalls to consider
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
Noninferiority trials are used to assess whether the effect of a new drug is not worse than an activ...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
Clinical investigators are increasingly testing treatments that have the primary benefit of decrease...
Understanding noninferiority trials Noninferiority trials test whether a new experimental treatment ...
Active-control noninferiority trials test the hypothesis that one intervention is no worse than anot...
Noninferiority trials, in which a new treatment is compared with a standard active treatment, are be...
Noninferiority trials test whether a new experimental treatment is not unacceptably less efficacious...
Active-control noninferiority trials are being performed with increas-ing frequency when standard pl...
When designing a noninferiority/equivalence trial, the sponsor intends to show efficacy by demonstra...
Discussions about the merits and shortcomings of non-inferiority trials are becoming increasingly co...
A randomized clinical trial (RCT) is the gold standard to evaluate the intended effects of drugs. In...
Noninferiority (NI) trials in drug research are used for the purpose of demonstrating that a new tre...
To explore characteristics of clinical trials that influence the choice of the noninferiority margin...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
Noninferiority trials are used to assess whether the effect of a new drug is not worse than an activ...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
Clinical investigators are increasingly testing treatments that have the primary benefit of decrease...
Understanding noninferiority trials Noninferiority trials test whether a new experimental treatment ...
Active-control noninferiority trials test the hypothesis that one intervention is no worse than anot...
Noninferiority trials, in which a new treatment is compared with a standard active treatment, are be...
Noninferiority trials test whether a new experimental treatment is not unacceptably less efficacious...
Active-control noninferiority trials are being performed with increas-ing frequency when standard pl...
When designing a noninferiority/equivalence trial, the sponsor intends to show efficacy by demonstra...
Discussions about the merits and shortcomings of non-inferiority trials are becoming increasingly co...
A randomized clinical trial (RCT) is the gold standard to evaluate the intended effects of drugs. In...
Noninferiority (NI) trials in drug research are used for the purpose of demonstrating that a new tre...
To explore characteristics of clinical trials that influence the choice of the noninferiority margin...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
The non-inferiority trial design has gained popularity within the last decades to compare a new trea...
Noninferiority trials are used to assess whether the effect of a new drug is not worse than an activ...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...